Quick answer: What makes real-world evidence regulatory-grade? Regulatory-grade real-world evidence (RWE) is evidence generated from…
genesisprdSeptember 21, 2026
Blog
The Research Hub Blog
Our thought leaders keep you up-to-date with the latest trends in RWE, HEOR, and market access.
Tim Wright, our Executive Vice President for Access and Pricing revisits the predictions on most-favored…
Richard ChumbleyJuly 23, 2026
At ISPOR 2026, our team presented on the topic of 'Navigating Strategies for Comparative…
Richard ChumbleyJuly 23, 2026
Prevalence of Obesity and Related Conditions and GLP-1 Use in Medicare Fee-for-Service Beneficiaries
We are delighted to share that a recent real‑world evidence (RWE) study on GLP‑1 receptor…
Richard ChumbleyJuly 22, 2026
In response to ISPOR's recently published 2026-2027 HEOR Trends, David Miller, CEO, Genesis Research Group,…
Richard ChumbleyJanuary 22, 2026
Originally published by The Evidence Base in both video and written format, republished here with…
Richard ChumbleyAugust 22, 2025
The Inflation Reduction Act (IRA) is setting new benchmarks for pharmaceutical pricing through Medicare's maximum…
Richard ChumbleyApril 1, 2025
Allowable for the first time due to the Inflation Reduction Act, the Centers for Medicare…
Richard ChumbleySeptember 12, 2024
The Evidence Base recently featured a 'deep dive' analysis of this ISPOR 2024 presentation. …
Richard ChumbleyJune 6, 2024
Want to keep up sith the latest RWE, HEOR, and market access trends?
Signup for our Newsletter
Headquarters:
HOBOKEN
111 River Street, Suite 1120
Hoboken, New Jersey 07030, US
